Total Payments
$32,564
2024 Payments
$17,133
Companies
10
Transactions
32
Medicare Patients
694
Medicare Billing
$81,285
Payment Breakdown by Category
Consulting$26,738 (82.1%)
Other$2,350 (7.2%)
Travel$2,329 (7.2%)
Food & Beverage$991.01 (3.0%)
Education$156.54 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $26,738 | 4 | 82.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,350 | 1 | 7.2% |
| Travel and Lodging | $2,329 | 5 | 7.2% |
| Food and Beverage | $991.01 | 21 | 3.0% |
| Education | $156.54 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $27,743 | 11 | $0 (2024) |
| Cook Incorporated | $2,350 | 1 | $0 (2024) |
| Novo Nordisk AS | $1,586 | 2 | $0 (2023) |
| Gilead Sciences, Inc. | $222.87 | 7 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $186.29 | 4 | $0 (2024) |
| Osteomed LLC | $156.54 | 1 | $0 (2021) |
| ABBVIE INC. | $135.99 | 2 | $0 (2024) |
| HISTOSONICS,INC. | $119.59 | 1 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $43.99 | 2 | $0 (2023) |
| ALBIREO PHARMA, INC. | $19.84 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,133 | 16 | Novo Nordisk Inc ($14,370) |
| 2023 | $15,072 | 12 | Novo Nordisk Inc ($13,372) |
| 2022 | $118.53 | 1 | ABBVIE INC. ($118.53) |
| 2021 | $240.50 | 3 | Osteomed LLC ($156.54) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Cook Incorporated | ECHOTIP INSIGHT (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,350.00 | General |
| Category: Endoscopy | ||||||
| 11/17/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $57.78 | General |
| Category: INFLAM | ||||||
| 10/31/2024 | ALBIREO PHARMA, INC. | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Rare Disease | ||||||
| 10/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.01 | General |
| 09/19/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $12,206.25 | General |
| 09/19/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $559.88 | General |
| 09/19/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $458.23 | General |
| 09/19/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $222.29 | General |
| 09/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $148.67 | General |
| 09/18/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $775.00 | General |
| 08/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.21 | General |
| 07/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $44.00 | General |
| 06/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.43 | General |
| 04/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $77.58 | General |
| Category: Gastroenterology | ||||||
| 01/09/2024 | HISTOSONICS,INC. | — | Food and Beverage | Cash or cash equivalent | $119.59 | General |
| 11/13/2023 | Novo Nordisk AS | — | Consulting Fee | Cash or cash equivalent | $1,550.00 | General |
| 11/13/2023 | Novo Nordisk AS | — | Food and Beverage | In-kind items and services | $36.19 | General |
| 10/12/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/05/2023 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $12,206.25 | General |
| 10/05/2023 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $1,015.47 | General |
| 10/05/2023 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $72.93 | General |
| 10/05/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $57.96 | General |
| 08/17/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Obesity | ||||||
| 06/29/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.22 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 250 | 328 | $100,809 | $27,923 |
| 2022 | 10 | 208 | 258 | $146,682 | $27,773 |
| 2021 | 10 | 211 | 276 | $125,105 | $24,372 |
| 2020 | 2 | 25 | 33 | $6,745 | $1,217 |
Total Patients
694
Total Services
895
Medicare Billing
$81,285
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 70 | 109 | $32,809 | $8,875 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 80 | 80 | $36,880 | $8,785 | 23.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 13 | 24 | $9,672 | $2,887 | 29.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 27 | $7,992 | $2,843 | 35.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 38 | $5,966 | $2,519 | 42.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 11 | 11 | $6,281 | $1,668 | 26.6% |
| 91200 | Measurement of liver stiffness | Facility | 2023 | 39 | 39 | $1,209 | $345.54 | 28.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 38 | $16,150 | $5,647 | 35.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 21 | 21 | $34,650 | $3,979 | 11.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 39 | $12,480 | $3,526 | 28.3% |
| 43244 | Tying of dilated veins of stomach and/or esophagus using a flexible endoscope | Facility | 2022 | 11 | 14 | $12,670 | $2,784 | 22.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 21 | 22 | $8,696 | $2,479 | 28.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 17 | 21 | $8,925 | $2,210 | 24.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $6,948 | $1,995 | 28.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 17 | 23 | $6,943 | $1,974 | 28.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 28 | $6,020 | $1,664 | 27.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 20 | 20 | $29,400 | $1,423 | 4.8% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 19 | 20 | $3,800 | $92.28 | 2.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 48 | $15,360 | $4,858 | 31.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 29 | 64 | $13,760 | $3,784 | 27.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 23 | $9,775 | $2,828 | 28.9% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 12 | 12 | $19,800 | $2,549 | 12.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 22 | 22 | $8,800 | $2,468 | 28.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $6,655 | $1,883 | 28.3% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 20 | 20 | $29,400 | $1,799 | 6.1% |
About Dr. Brian Lee, MD
Dr. Brian Lee, MD is a Transplant Hepatology healthcare provider based in San Bernardino, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2013. The National Provider Identifier (NPI) number assigned to this provider is 1346583242.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Lee, MD has received a total of $32,564 in payments from pharmaceutical and medical device companies, with $17,133 received in 2024. These payments were reported across 32 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($26,738).
As a Medicare-enrolled provider, Lee has provided services to 694 Medicare beneficiaries, totaling 895 services with total Medicare billing of $81,285. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Transplant Hepatology
- Location San Bernardino, CA
- Active Since 03/29/2013
- Last Updated 08/20/2020
- Taxonomy Code 207RT0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346583242
Products in Payments
- ECHOTIP INSIGHT (Device) $2,350
- XIFAXAN (Drug) $186.29
- CMF-CFx (Device) $156.54
- MAVYRET (Drug) $118.53
- Livdelzi (Drug) $57.78
- OCALIVA (Drug) $43.99
- IQIRVO (Drug) $19.84
- Wegovy (Drug) $19.62
- LINZESS (Drug) $17.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.